Tmunity Therapeutics

Leveraging the immunological potential of T cells to treat a wide range of diseases

placePhiladelphia, Pennsylvania, United States calendar_todayFounded 2015 groups43 employees language tmunity.com

Registered entities

Innovation

5 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 47 times.

YearFilings
20211
20222
20234
20242
20251

Investor mix

11 investors on record; lead investors include Ping An Ventures, Lilly Asia Ventures, Andreessen Horowitz, Kleiner Perkins; 1 has since exited.

Investor typeCountShare
Venture capital545%
Other / undisclosed655%
Coming soon